ArticleProstate cancer and prostatic diseases2024

Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.

Anita Csizmarik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.